Performance Update on World Health Organisation SARS-CoV2 Serology Standards
Halifax, Nova Scotia, 14 June, 2021 – MedMira Inc. (MedMira) (TSXV: MIR) announces the World Health Organization (WHO) SARS-CoV-2...
Performance Update on World Health Organisation SARS-CoV2 Serology Standards
Product and Regulatory Update on MedMira’s COVID-19 Product Family
Progress Update on MedMira’s COVID-19 Product Family
MedMira Announces Product Update
MedMira reports additional independent performance evaluation results of REVEALCOVID-19™
MedMira Announces Update on Development of Point-of-Care Antibody Test